← Eichor
Condition: Advanced Anal Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Advanced Anal Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial
Phase 1 · 12 location(s) · EvolveImmune United, Inc · NCT07217171Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
Phase 2 · 1 location(s) · University of Chicago · NCT06669572A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Phase 1/Phase 2 · 8 location(s) · LigaChem Biosciences, Inc. · NCT05941507IMRT Versus IMPT With Concurrent Chemotherapy for Locally Advanced Anal Canal Cancer
NA · 1 location(s) · Tata Memorial Centre · NCT06630793Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 · 6 location(s) · Pliant Therapeutics, Inc. · NCT06270706Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy f
Phase 3 · 114 location(s) · Federation Francophone de Cancerologie Digestive · NCT06207981SMP-3124LP in Adults With Advanced Solid Tumors
Phase 1/Phase 2 · 10 location(s) · Sumitomo Pharma America, Inc. · NCT06526819ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer
Phase 2 · 2 location(s) · Jennifer Dorth · NCT07425054Adaptive Radiation in Anal Cancer
NA · 1 location(s) · Columbia University · NCT05838391E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Phase 1/Phase 2 · 2 location(s) · Christian Hinrichs · NCT05639972SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
Phase 1 · 1 location(s) · The Affiliated Hospital of Qingdao University · NCT06544720Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced
Phase 1 · 20 location(s) · Bicara Therapeutics · NCT04429542
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.